NCT02330497View on ClinicalTrials.gov

Efficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic Tumor

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Pancreatic TumorEndocrine TumorNeoplasms, Cystic, Mucinous, and Serous
Interventions
PROCEDURE

Radiofrequency Ablation under EUS

Pancreatic radiofrequency ablation under endoscopic ultrasonography guidance Procedure under general anesthesia Punction of the pancreatic lesion and aspiration of the liquid if present / then thermal ablation with a 18G needle (50 W during 10 secondes) - only one session

Trial Locations (1)

13000

Barthet, Marseille

All Listed Sponsors
lead

Société Française d'Endoscopie Digestive

OTHER

NCT02330497 - Efficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic Tumor | Biotech Hunter | Biotech Hunter